Somatic Genetic Testing: A Leading Driver Behind Increasing Incidence Of Cancer Fueling The Growth Of The Market Due To Rising Demand For Early And Personalized Diagnosis Market Expansion in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Somatic Genetic Testing Industry Market Size Be by 2025?
In recent times, there has been a swift expansion in the size of the somatic genetic testing market. It is projected to increase from $6.81 billion in 2024 to $7.78 billion in 2025, with a compound annual growth rate (CAGR) of 14.3%. The surge during the historical period can be linked to a heightened awareness of genetic diseases, an escalating number of cancer instances, more widespread use of genetic testing in clinical settings, growth in healthcare infrastructure, and an increasing demand from patients for customized treatment.

What's the Long-Term Growth Forecast for the Somatic Genetic Testing Market Size Through 2029?
The market size of somatic genetic testing is projected to experience robust expansion in the coming few years, with its value soaring to $13.13 billion in 2029 at a compound annual growth rate (CAGR) of 14.0%. This advancement during the prediction period can be ascribed to the escalating focus on early diagnosis of illnesses, rising partnerships between biotech and pharmaceutical entities, burgeoning public-private collaborations, and the augmenting accessibility of diagnostic gadgets. Foremost trends during the prediction span consist of advancements in sequencing technology, revolutions in bioinformatics and artificial intelligence, capital inputs in research and development, emergence of non-intrusive testing procedures, and breakthroughs in next-generation sequencing platforms.

View the full report here:
https://www.thebusinessresearchcompany.com/report/somatic-genetic-testing-global-market-report

What Are the Key Growth Drivers Fueling the Somatic Genetic Testing Market Expansion?
The growth of the somatic genetic testing market is being driven by the rising occurrence of cancer. This refers to a collection of illnesses marked by unrestricted proliferation and dissemination of abnormal body cells. The increasing burden of cancer can be attributed to lifestyle choices such as unhealthy eating habits, smoking, lack of physical activity, and overconsumption of alcohol. Somatic genetic testing has a significant role in cancer diagnosis, as it can identify genetic mutations specific to tumors, thereby facilitating individualized and targeted treatment strategies. It cuts down on intrusive procedures through the use of cutting-edge technologies, enhancing the precision of diagnosis and improving patient outcomes. For instance, the Australian Institute of Health and Welfare, a government agency based in Australia, claimed in July 2024 that the total cancer cases diagnosed in Australia escalated to 160,570 in 2022 from 156,781 in 2021, reflecting an increase of 3,789 cases. As a result, the upsurge in cancer incidence is fueling the expansion of the somatic genetic testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27421&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Somatic Genetic Testing Market?
Leading firms in the somatic genetic testing market are focused on crafting cutting-edge diagnostic solutions, such as liquid biopsies, to enhance precision, facilitate early detection, and minimize the reliance on invasive procedures. Liquid biopsies are non-invasive techniques that scrutinize circulating tumor DNA (ctDNA) or other biomarkers present in blood samples to identify genetic changes associated with cancer. Example: in September 2024, Strand Life Sciences, a company based in India specializing in genomics and bioinformatics, introduced the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test. This new-age liquid biopsy test is designed to detect ctDNA from blood samples. The SA74-LB test, powered by next-generation sequencing (NGS), is targeted at discovering somatic mutations across 74 crucial cancer-related genes. This test is instrumental in tailoring cancer treatment by pinpointing actionable mutations, tracking treatment outcomes, and identifying minimal residual disease (MRD) without the necessity for conventional tissue biopsies. Moreover, it bolsters precision oncology by guiding targeted therapies and closely monitoring disease evolution or resistance in real-time.

How Is the Somatic Genetic Testing Market Segmented?
The somatic genetic testing market covered in this report is segmented

1) By Type: Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Carrier Screening, Other Testing Methods
2) By Sample: Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples
3) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies
4) By Application: Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Inherited Genetic Disorders, Other Applications
5) By End-User: Hospitals, Clinical Laboratories, Research Institutes, At-Home Testing Providers, Other End-Users

Subsegments:
1) By Targeted Gene Panels: Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels
2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing
3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing
4) By Carrier Screening: Expanded Carrier Screening, Ethnicity-Based Carrier Screening, Universal Carrier Screening
5) By Other Testing Methods: Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27421&type=smp

Which Companies Are Leading the Charge in Somatic Genetic Testing Market Innovation?
Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., and Circulogene Theranostics LLC.

Which Regions Are Leading the Global Somatic Genetic Testing Market in Revenue?
North America was the largest region in the somatic genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27421

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.